With the emergence and long-term Impact of COVID-19, Global Cell Culture Media Market to reach USD 17.51 billion by 2030
Bizwit Research & Consulting LLP’s recent analysis on the Global Cell Culture Media Market points towards a potential rise to USD 17.51 billion by 2030. Cell culture media, referred to as growth media, is a specialized gel or liquid designed to supply isolated cells with vital nutrients and growth factors required for their survival, division, and functioning in a controlled setting outside their natural organism. It aims to closely mimic the cells’ natural environment, allowing researchers and scientists to investigate cell behavior, formulate drugs, and even engineer tissues.
The composition of cell culture media is carefully designed to provide the essential nutrients, growth factors, hormones, salts, vitamins, and other critical elements needed for the cells to survive and replicate. The media also contain serum, which is derived from animal blood and provides additional nutrients and growth factors. The global market growth is being driven by factors such as growth in stem cell research, emerging cell culture technologies for cell-based vaccines, surge in production of vaccines, increasing demand for monoclonal antibodies and biosimilars, coupled with the rising emphasis on personalized medicine.
Geographically, the global Cell Culture Media market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA). North America dominated the market in 2022 owing to the expansion of the biotechnology and pharmaceutical sectors, the increasing number of vaccines based on cell culture receiving approvals, the rising prevalence of illnesses such as cancer, and the growing funding and investments made in cell-based research. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The increasing development of biopharmaceuticals, oncology, and stem cell research, as well as the surge in demand for life science research are significantly propelling the market demand across the region.
Furthermore, the rise in the number of strategic activities by key industry players to expand their presence in the Asia Pacific countries is also presenting high growth prospects for market expansion. For instance, in December 2021, Fujifilm Irvine Scientific, Inc. started the construction of its new bioprocessing center in China, intending to ensure cell culture media optimization support for biotherapeutic drug development, vaccines, and advanced therapies. For instance, in December 2021, Fujifilm Irvine Scientific, Inc. announced the construction of a new bioprocessing center in China, which aims to offer comprehensive support for cell culture media optimization in the development of biotherapeutic drugs, vaccines, and advanced therapies.
The global Cell Culture Media market is highly competitive owing to the presence of several key players such as Thermo Fisher Scientific, Inc. (US) Merck KGaA (Germany) Danaher Corporation (US) Sartorius AG (Germany) Corning Incorporated (US) FUJIFILM Irvine Scientific, Inc. (Japan) Lonza Group (Switzerland) Becton, Dickinson and Company (US) Miltenyi Biotec (Germany) HiMedia Laboratories Pvt. Ltd. (India), and others.
For further analysis on this or to request a sample copy of this report, please click the link mentioned below:
Key findings of the study suggest:
- Global Cell Culture Media Market is anticipated to grow with a healthy growth rate of more than 16% over the forecast period 2023-2030.
- In the Type segment, Serum-free Media emerged out as the leading market segment in 2022.
- North America is anticipated to drive regional growth owing to expansion of the biotechnology and pharmaceutical sectors in the region.
- Asia Pacific is expected to grow at higher rate owing to increasing development of biopharmaceuticals, oncology, and stem cell research in the region
Bizwit Research & Consulting has considered following segments for the study:
By Type:
- Serum-free Media
- Classical Media & Salts
- Stem Cell Culture Media
- Specialty Media
- Chemically Defined Media
- Other Cell Culture Media
By Application:
- Biopharmaceutical Production
- Diagnostics
- Drug Screening & Development
- Tissue Engineering & Regenerative Medicine
- Other Applications
By End user:
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Research & Academic Institutes
- Other End Users
Regional Outlook
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
To get a sample of this report or to purchase a copy of the study, you can directly contact us at: sales@bizwitresearch.com
About Us
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. The company has a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. Bizwit incorporate big data, expert analysis, and huge industry database to deliver client focused business consulting reports. Our analysts perform unbiased measurement and assessment of market opportunities to comprehend detailed market forecast. Our team of key opinion leaders evaluates the market size, growth prospects, end-use, applications, value & supply chain and top vendors in the industry to help the clients to take conversant business decisions without any vague assumptions.
Contact US
Global Business Development
Phone: +1 209 498-3066
Email: Sales@bizwitresearch.com
Website: www.bizwitresearch.com
